Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2000
08/24/2000WO2000023100A9 Genes and proteins predictive and therapeutic for renal disease and associated disorders
08/24/2000WO2000022113A9 ENZYMATIC SYNTHESIS OF ssDNA
08/24/2000WO2000020025A9 Akt compositions for enhancing survival of cells
08/24/2000WO2000015797A3 Compositions and methods for the treatment of immune related diseases
08/24/2000WO2000015783A9 ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO β1-ADRENOCEPTOR-SPECIFIC mRNA AND METHODS OF USE
08/24/2000WO2000010611A3 Drug targeting
08/24/2000WO2000010536A9 Extended release buccal bioadhesive tablet
08/24/2000WO1999034763A3 Pharmaceutical compositions comprising thiram for inhibiting angiogenesis
08/24/2000WO1996012697A9 Calcium receptor-active compounds
08/24/2000DE19908753A1 Oligomer-polymer composition containing biodegradable polymers of hydroxycarboxylic acids, useful as injectable implant for administration of various drugs
08/24/2000DE19907385A1 New 3-(phenoxy or phenylalkoxy)-2-phenyl-propylamines, useful for treating e.g. arrhythmia, spasms, pain or neurodegenerative diseases, are tension-dependent sodium channel blockers
08/24/2000CA2371824A1 .beta.-alanine derivatives
08/24/2000CA2362943A1 Pyk2 binding proteins
08/24/2000CA2362334A1 Dibenzo-azepine derivatives as .alpha.v integrin receptor antagonists
08/24/2000CA2362330A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
08/24/2000CA2362300A1 Human lipid-associated proteins
08/24/2000CA2361273A1 Inhibitors for use in hemostasis and immune function
08/24/2000CA2329524A1 Intermittent claudication therapeutic drugs comprising pyrroloazepines
08/23/2000EP1029921A1 Serpin resistant chymotrpsin superfamily proteases, particularly PAI-1 resistant t-PA, complementary inhibitor mutants; compositions; genes; expressions
08/23/2000EP1029872A1 Piperazine-cyclodextrin complexes
08/23/2000EP1029870A2 Hybrid Immunoglobulins
08/23/2000EP1029869A1 Endothelin converting enzyme inhibitors
08/23/2000EP1029865A2 Process and intermediates for preparing 5-lipoxygenase inhibitors
08/23/2000EP1029548A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution
08/23/2000EP1029540A2 Use of droloxifene for the treatment of cardiovascular diseases
08/23/2000EP1028975A1 Artemin, a novel neurotrophic factor
08/23/2000EP1028958A1 Arylpiperazines as serotonin reuptake inhibitors and 5-ht1d alpha antagonists
08/23/2000EP1028956A1 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
08/23/2000EP1028955A1 Pyrimidinone compounds and pharmaceutical compositions containing them
08/23/2000EP1028948A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists
08/23/2000EP1028947A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type
08/23/2000EP1028946A1 Indazole bioisostere replacement of catechol in therapeutically active compounds
08/23/2000EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents
08/23/2000EP1028942A2 Dipeptide nitriles
08/23/2000EP1028735A1 Therapeutic methods comprising use of a neuregulin
08/23/2000EP1028730A1 Compositions of lipid lowering agents
08/23/2000EP1028728A1 Use of quinapril for treating myocardial ischemia and angina
08/23/2000EP1028717A2 Unsubstituted polydiallylamine for treating hypercholesterolemia
08/23/2000EP1028716A1 Method for treating and preventing heart failure and ventricular dilatation
08/23/2000EP1028708A1 Topical compositions for prostaglandin e 1? delivery
08/23/2000CN1264426A Ligand 0(cluding antibody) for display aimed-at endocrine cell reactivity
08/23/2000CN1264384A Fused 1,2,4-thiadiazine derivatives, their preparation method and use
08/23/2000CN1264382A Novel compounds
08/23/2000CN1264381A 4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists
08/23/2000CN1264379A Piperazine derivatives
08/23/2000CN1264377A Substituted pyrazoles as P38 kinase inhabitors
08/23/2000CN1264376A 3(5)-Heteroaryl substituted pyrazoles as P38 kinase inhibitors
08/23/2000CN1264375A Crystal modification of N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
08/23/2000CN1264366A Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-[2-(2-methoxyphenoxy) ethylamino]-2-propanole, process for its preparation and pharmaceutical compositions containing it
08/23/2000CN1263763A Drug composition containing carboxyl oxime acide derivative
08/23/2000CN1055700C Therapeutic peptide derivatives
08/23/2000CN1055691C 3-alkylcarbonyl-thiadiazinenone
08/23/2000CN1055690C 4-aryloxy-and-4-arylthiopiperidine derivatives, method for preparation them, medicine compound containing them and use thereof
08/23/2000CN1055684C Method for preparing substituted pyridine
08/23/2000CN1055640C Human calcium degrading gene concerned peptide fatty composite and preparation thereof
08/23/2000CN1055628C Deficency-cold anal-gut pill
08/22/2000USRE36832 N-heteroaryl-N'-phenylurea derivatives, their production and use
08/22/2000US6107517 Thyroid hormone agonists and antagonists
08/22/2000US6107473 Kringle-related clone HTHBZ47
08/22/2000US6107334 Dietary control of arachidonic acid metabolism
08/22/2000US6107328 Use of 5HT1B receptor antagonist for the treatment of vascular disease
08/22/2000US6107324 5-HT2A receptor inverse agonists
08/22/2000US6107323 Preventing or treating angiotensin diseases by administering an antagonist and compound which increases insulin sensitivity
08/22/2000US6107315 Nervous system disorders
08/22/2000US6107310 Heteroarylcarboxamide derivatives for treating CNS disorders
08/22/2000US6107306 Heterocyclic compounds
08/22/2000US6107294 Nervous system and psychological disorders
08/22/2000US6107291 Antiinflammatory agent
08/22/2000US6107280 Administering bactericidal/permeability-increasing protein to delay or prevent clot formation in the blood or to enhance clot dissolution in blood
08/22/2000US6107075 Human elastase IV
08/22/2000US6106858 Loading active materials of liposomes by dissolving
08/22/2000US6106830 Methods for the treatment of apoptosis-related diseases by batroxobin
08/22/2000US6106822 Hormone and growth factor phosphoglycokine mimetics from mycobacterium
08/22/2000CA2165992C Disulphides
08/22/2000CA2111002C Non-chlorofluorocarbon aerosol formulations
08/22/2000CA2016627C Proteinase inhibitors, process for the preparation thereof and medicaments containing these
08/17/2000WO2000047734A1 Inhibiting formation of atherosclerotic lesions
08/17/2000WO2000047716A2 Fibres for culturing eukaryotic cells
08/17/2000WO2000047624A1 Dihydroouabain-like factor and diagnostic and therapeutic compositions and methods
08/17/2000WO2000047622A2 Peptides with anti-angiogenic activity
08/17/2000WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation
08/17/2000WO2000047603A2 16-hydroxyestratrienes as selective estrogens
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047596A1 Method for purifying a red fruit extract containing anthocyanosides
08/17/2000WO2000047583A1 Cyclic substituted fused pyrrolocarbazoles and isoindolones
08/17/2000WO2000047580A2 Phenyl urea and phenyl thiourea derivatives
08/17/2000WO2000047578A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000WO2000047575A1 Pyrrole derivatives and cell death inhibitors
08/17/2000WO2000047574A1 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents
08/17/2000WO2000047573A1 Heterocyclic derivatives as inhibitors of factor xa
08/17/2000WO2000047572A1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
08/17/2000WO2000047568A2 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
08/17/2000WO2000047564A1 Novel guanidine derivatives as inhibitors of cell adhesion
08/17/2000WO2000047563A1 LACTAM INHIBITORS OF FXa AND METHOD
08/17/2000WO2000047562A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000WO2000047554A2 INHIBITORS OF FACTOR Xa
08/17/2000WO2000047553A2 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
08/17/2000WO2000047552A1 Tyrosine alkoxyguanidines as integrin inhibitors
08/17/2000WO2000047284A2 Novel use of orexin receptor antagonists
08/17/2000WO2000047238A1 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients
1 ... 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 ... 1595